Martek Biosciences Corp., Columbia, MD, and Mission Pharmacal Company, San Antonio, TX, have entered into a five-year license and supply agreement. This new agreement provides for the continued supply of Martek’s life’sDHA to Mission Pharmacal. Under the terms of this agreement, Mission Pharmacal has agreed to purchase all of its DHA omega 3 needs from Martek for prescription pregnancy and nursing products in the U.S. and other designated territories. There are no minimum purchase requirements or other financial commitments to Martek. Mission Pharmacal will continue to display the life’sDHA logo on the product packaging, and it will also include the life’sDHA logo in related marketing, advertising and promotional materials.

Life’sDHA is unique in the market because it is derived from a sustainable and vegetarian source. Made from microalgae under tightly controlled manufacturing conditions, life’sDHA is free of oceanic contaminants that may be present in certain fish or fish oils. In January of 2006, Mission Pharmacal successfully introduced Citracal Prenatal + DHA with life’sDHA as part of its prescription prenatal vitamin product line. Since its introduction, Citracal Prenatal + DHA has rapidly established itself as one of the leading brands of prescription prenatal products that contain DHA, a key ingredient for infant brain and eye development. The Citracal prenatal pack contains a balanced daily dose of prescription-strength vitamins and minerals in a tablet and a 250 mg capsule of life’sDHA. Citracal Prenatal + DHA is intended to improve the nutritional status of women prior to conception, throughout pregnancy and in the postnatal period for both lactating and non-lactating mothers.